Oncology Institute (DFPH) Debt to Equity (2020 - 2025)
Historic Debt to Equity for Oncology Institute (DFPH) over the last 6 years, with Q3 2025 value amounting to -$6.21.
- Oncology Institute's Debt to Equity fell 20499.55% to -$6.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.21, marking a year-over-year decrease of 20499.55%. This contributed to the annual value of $25.95 for FY2024, which is 160426.18% up from last year.
- Latest data reveals that Oncology Institute reported Debt to Equity of -$6.21 as of Q3 2025, which was down 20499.55% from -$8.35 recorded in Q2 2025.
- Over the past 5 years, Oncology Institute's Debt to Equity peaked at $25.95 during Q4 2024, and registered a low of -$8.35 during Q2 2025.
- Over the past 5 years, Oncology Institute's median Debt to Equity value was $1.09 (recorded in 2023), while the average stood at $3.06.
- As far as peak fluctuations go, Oncology Institute's Debt to Equity soared by 3715386.37% in 2022, and later tumbled by 37111.11% in 2025.
- Quarter analysis of 5 years shows Oncology Institute's Debt to Equity stood at $0.0 in 2021, then skyrocketed by 37153.86% to $0.65 in 2022, then skyrocketed by 132.63% to $1.52 in 2023, then skyrocketed by 1604.26% to $25.95 in 2024, then plummeted by 123.92% to -$6.21 in 2025.
- Its Debt to Equity stands at -$6.21 for Q3 2025, versus -$8.35 for Q2 2025 and $14.58 for Q1 2025.